Hearing Loss and Hypothyroidism: What the Evidence Shows

Hypothyroidism can contribute to sensorineural hearing loss through cochlear changes. The effect is modest in most adults and partly reversible on adequate levothyroxine, but persistent hearing loss needs an audiology workup.

Why hypothyroidism can affect hearing

The cochlea — the snail-shaped inner-ear organ that turns vibration into nerve signals — is one of the most thyroid-hormone-dependent structures in the body. Thyroid hormone regulates the development of cochlear hair cells and synapses, and adult cochlear function continues to depend on normal hormone levels for fluid balance and nerve signaling [C3][C5].

Three distinct mechanisms can connect hypothyroidism to hearing loss:

• Cochlear myxedema. In adult-onset hypothyroidism, glycosaminoglycan deposition in the inner ear — the same myxedematous tissue changes seen elsewhere in severe hypothyroidism — can alter cochlear fluid dynamics and dampen sound transmission [C2][C5]. Audiometry in patients with newly diagnosed primary hypothyroidism has shown measurable sensorineural thresholds that partly improve as TSH normalizes [C5].
• Autoimmune inner-ear disease. In Hashimoto's and other autoimmune thyroid diseases, antibodies and immune-mediated inflammation may target inner-ear structures independently of thyroid hormone status. This is why some patients with normal TSH on levothyroxine still develop hearing loss — the autoimmune process is separate from the hormonal one [C6][C7].
• Pendred syndrome. A genetic cause of congenital sensorineural hearing loss combined with goiter, due to mutations in the SLC26A4 gene. It accounts for up to 7–10% of congenital hearing loss cases and is identified through newborn hearing screening plus genetic testing [C4].

Clinical pattern

In adults with acquired hypothyroidism, the hearing loss is usually [C3][C5]:

• Bilateral and symmetric, affecting both ears similarly
• Mild to moderate in severity — typically a 10–25 dB loss across the high frequencies, sometimes more in severe long-standing disease
• Sensorineural (inner ear or nerve), not conductive (middle ear)
• Gradual, developing over months to years alongside other hypothyroid symptoms
• Sometimes accompanied by tinnitus, a sense of fullness, or mild balance problems — see our Hashimoto tinnitus article

Childhood hypothyroidism is different. A 2022 meta-analysis found that even with newborn screening and early treatment, mild-to-moderate sensorineural hearing loss is more common in children with congenital hypothyroidism than in controls — because thyroid hormone shapes cochlear development in the first months of life [C3].

What recovers on adequate levothyroxine

Once TSH is brought into the normal range on levothyroxine, several auditory features can improve over weeks to months [C1][C5]:

• High-frequency thresholds often shift back toward baseline as cochlear fluid and metabolism normalize
• Aural fullness and mild low-frequency loss tend to resolve earlier than high-frequency loss
• Speech discrimination in quiet usually improves as overall thresholds improve

Recovery is partial, not guaranteed. In Psaltakos' study of newly diagnosed hypothyroid patients, audiometric thresholds improved significantly after 3 months of levothyroxine but did not fully return to age-matched normal levels in every patient [C5]. Long-standing or severe hypothyroidism produces less reversible loss [C2][C3].

When hearing loss persists — differential

If hearing loss does not improve after several months of well-controlled TSH, your endocrinologist will typically coordinate with an audiologist or ENT to consider [C1][C8]:

1. Presbycusis (age-related hearing loss). This is the most common cause of adult sensorineural hearing loss and is independent of thyroid status. It is typically high-frequency, bilateral, and progressive — sometimes overlapping with mild thyroid-related loss. Distinguishing them often requires serial audiograms and the patient's age, noise exposure, and family history [C8].
2. Autoimmune inner-ear disease. In Hashimoto patients, antibody-mediated cochlear damage can continue despite normal TSH. The 2019 Rodríguez-Valiente study found that L-thyroxine alone did not prevent ongoing sensorineural hearing loss in patients with autoimmune thyroid disease [C6][C7].
3. Noise-induced hearing loss. Often asymmetric, with a characteristic notch around 4 kHz.
4. Sudden sensorineural hearing loss. A rapid, often unilateral loss — this is a medical emergency requiring urgent ENT evaluation within 72 hours, regardless of thyroid status.
5. Ototoxic medications. Aminoglycosides, loop diuretics, cisplatin, and high-dose aspirin can cause sensorineural loss. Review the medication list with your endocrinologist.
6. Ménière's disease. Episodic vertigo plus fluctuating low-frequency hearing loss — has been described more often in patients with hypothyroidism than in the general population but usually has a separate ENT workup [C2].

What does NOT help

Several heavily-marketed approaches have no clinical evidence for thyroid-related hearing loss [C1][C8]:

• "Thyroid support" multivitamin blends — usually contain iodine, biotin, kelp, and ashwagandha. Iodine can destabilize Hashimoto's; biotin interferes with thyroid lab measurement. Neither restores hearing.
• High-dose biotin for hearing or tinnitus. No clinical evidence, and it falsely lowers TSH and free T4 readings on common immunoassays.
• Hyperbaric oxygen outside of sudden sensorineural hearing loss within 2 weeks of onset — outside that window, the evidence is weak.
• Switching from levothyroxine to "natural desiccated thyroid" specifically to improve hearing. The ATA still recommends levothyroxine as first-line for hypothyroidism, and there is no audiometric evidence that desiccated thyroid is superior [C1].
• Detox protocols, "ear candling," and herbal blends — no evidence; ear candling can cause burns and ear-canal damage.

Practical guidelines

1. Confirm TSH is in target range. Most thyroid-related auditory symptoms improve once TSH stabilizes in the normal range on levothyroxine [C1].
2. Tell your endocrinologist if you notice new hearing loss, tinnitus, or a sense of fullness in the ears. These can be early signs of either hypothyroidism worsening or a separate ENT issue [C1][C2].
3. Get a baseline audiogram if hearing loss is suspected. An audiologist will measure thresholds across frequencies — this is the only way to quantify and track the loss [C8].
4. Refer to ENT urgently for sudden unilateral hearing loss. This is a medical emergency regardless of thyroid status — early treatment within 72 hours improves outcomes.
5. Recheck hearing after 3–6 months of stable TSH if you had baseline loss. Improvement supports a hypothyroid contribution; persistent loss points to other causes [C5].
6. Don't add high-dose biotin, iodine, or "ear health" supplements without specific medical indication — they can complicate thyroid lab interpretation without improving hearing [C8].

Frequently asked questions

Will my hearing come back on levothyroxine? Many adults with hypothyroidism-related hearing loss see partial improvement after 3 to 6 months of stable TSH, especially for mild high-frequency loss and aural fullness [C5]. Severe or long-standing loss is less reversible, and Hashimoto patients with autoimmune inner-ear involvement may not fully recover [C6].

Will levothyroxine cure hearing loss caused by Hashimoto's? No. Levothyroxine corrects the hormone deficiency, but it does not stop the underlying autoimmune process. The 2019 Rodríguez-Valiente study showed that L-thyroxine alone did not prevent ongoing immune-mediated sensorineural hearing loss in patients with autoimmune thyroid disease [C6][C7]. Persistent loss needs separate ENT and audiology management.

How do I tell thyroid hearing loss from age-related hearing loss? Both are typically bilateral and high-frequency, so they are hard to distinguish by symptoms alone. Two clues: thyroid-related loss often improves after TSH stabilizes, while presbycusis progresses slowly with age regardless of treatment. Serial audiograms before and after starting levothyroxine are the most useful test [C5][C8].

Should I be screened for Pendred syndrome? Pendred syndrome is screened in infants through newborn hearing tests combined with thyroid function and, if suspected, genetic testing for SLC26A4 mutations [C4]. Adults who develop hypothyroidism without congenital hearing loss almost never have Pendred — it is a developmental disorder, not an adult-onset condition.

Can subclinical hypothyroidism cause hearing loss? The data are mixed. Mild changes in high-frequency thresholds have been reported, but the effect is small and not consistently seen across studies. Hearing loss alone is not a reason to start levothyroxine for subclinical hypothyroidism — that decision rests on TSH, antibodies, symptoms, and pregnancy plans [C1].

Bottom line

Hypothyroidism can contribute to sensorineural hearing loss through cochlear changes — fluid dynamics in adults, developmental delay in congenital cases, and autoimmune inflammation in Hashimoto's [C2][C3][C5]. The effect on adults is usually modest and partly reversible once TSH is stable in the normal range on levothyroxine [C1][C5]. Persistent loss, asymmetric loss, or sudden loss needs urgent audiology and ENT evaluation, regardless of thyroid status [C6][C8]. There is no shortcut — the right path is the correct levothyroxine dose, a baseline audiogram, and timely referral when needed.